PMID: 26236730 Gwyer D, Wragg NM, Wilson SL
By blocking NNMT activity, it increases critical cellular metabolites (SAM, NAD) that drive downstream increases in energy expenditure and metabolic health 1-4
Tirzepatide, used in Zepbound and Mounjaro, targets both the GLP-1 and the GIP receptor agonist, while semaglutide, found in Wegovy and Ozempic, mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver
For a non-dosing background guide, see Peptide Advisors' tesamorelin + ipamorelin blend overview
Inject under the skin (subcutaneously) only
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice